Search

Edwards Lifesciences Corp

Cerrado

SectorSanidad

88.99 -0.95

Resumen

Variación precio

24h

Actual

Mínimo

87.93

Máximo

90.17

Métricas clave

By Trading Economics

Ingresos

-139M

241M

Ventas

92M

1.7B

P/B

Media del Sector

51.917

49.241

BPA

0.78

Margen de beneficios

13.866

Empleados

16,000

EBITDA

62M

562M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+18% upside

Dividendos

By Acuity

Próximas Ganancias

4 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

1.3B

50B

Apertura anterior

89.94

Cierre anterior

88.99

Edwards Lifesciences Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

22 oct 2026, 20:03 UTC

News

Edwards Lifesciences prepares for the TCT 2026 meeting, with Stifel noting high expectations for PROGRESS trial data release on November 2.

21 oct 2026, 20:07 UTC

News

Edwards Lifesciences receives FDA approval for its PASCAL Precision System for tricuspid valve repair, enhancing its transcatheter valve therapy portfolio.

20 oct 2026, 20:08 UTC

Edwards Lifesciences Corp shares advanced, supported by strong performance in the health care equipment sector, maintaining an upward trajectory throughout the day.

19 oct 2026, 20:07 UTC

Edwards Lifesciences Corp shares are modestly higher, having peaked early before retracing to close near the lower end of the day's range.

16 oct 2026, 20:07 UTC

News

Edwards Lifesciences faces pressure after an FDA alert on the recall of its Commander M delivery systems linked to balloon bursts, resulting in one death.

15 oct 2026, 20:02 UTC

Edwards Lifesciences Corp shares are advancing, reaching a high and positioned above its 20-day moving average.

13 oct 2026, 19:26 UTC

Edwards Lifesciences Corp shares fell, shifting from early gains to losses, amid broader weakness in the health care equipment sector and trading below the 20-day moving average.

12 oct 2026, 23:06 UTC

Edwards Lifesciences Corp shares are trading modestly lower in after-market hours, retracing from an earlier peak amid recent volatility.

9 oct 2026, 20:01 UTC

Edwards Lifesciences Corp shares are higher, benefiting from gains in the Health Care Equipment sub-sector, despite a divergence from recent upward trends.

8 oct 2026, 20:01 UTC

Edwards Lifesciences Corp shares are lower, breaking a trend of higher daily closes amid diverging broader market conditions.

7 oct 2026, 20:50 UTC

Edwards Lifesciences Corp declined in after-market trading, continuing a trend of three consecutive sessions lower and remaining below its 20-day moving average.

6 oct 2026, 19:15 UTC

Edwards Lifesciences Corp shares are declining, following unusual volatility, and have fallen to their lowest point of the day amid a cumulative loss since Monday.

5 oct 2026, 20:02 UTC

Social Media
News

Edwards Lifesciences plans an investor event on November 2, 2026, and is on Citi's 90-Day Upside Catalyst Watch List, contributing to its higher trading today.

2 oct 2026, 20:07 UTC

News

Edwards Lifesciences shares fell despite FDA approval of the AUTUS Size-Adjustable Valve for pediatric patients, designed to reduce the need for multiple surgeries.

1 oct 2026, 20:02 UTC

Edwards Lifesciences Corp shares fell sharply, pulling back from an early gain and trading below the 20-day moving average, nearing the lower end of its one-month range.

30 sept 2026, 20:07 UTC

Edwards Lifesciences Corp shares fell sharply, continuing a downward trend and remaining below their 20-day moving average despite a brief recovery earlier in the session.

29 sept 2026, 22:01 UTC

Edwards Lifesciences Corp is trading modestly lower in after-market hours, with its cumulative return showing more pronounced losses following four consecutive higher sessions.

28 sept 2026, 21:21 UTC

Edwards Lifesciences Corp traded modestly lower during after-market hours, remaining 1.39% below its 20-day moving average.

23 sept 2026, 20:02 UTC

Edwards Lifesciences Corp shares fell sharply, remaining well below their 20-day moving average and near the lower end of their one-month range.

22 sept 2026, 23:01 UTC

Edwards Lifesciences Corp is trading modestly higher in after-market hours, nearing the upper end of its one-month trading range.

17 sept 2026, 20:07 UTC

Edwards Lifesciences Corp shares fell sharply on Thursday, continuing a downward trend that began after Wednesday's close, despite peaking in the morning.

16 sept 2026, 23:41 UTC

Edwards Lifesciences Corp saw a modest decline in after-hours trading, continuing a downward trend that has intensified since Wednesday's close.

15 sept 2026, 20:51 UTC

Edwards Lifesciences shares are lower in after-market trading. Broader market sentiment is pressured by rising crude oil prices amid geopolitical tensions in the Middle East.

14 sept 2026, 20:08 UTC

Edwards Lifesciences Corp shares are higher during Monday's session, reflecting an upward trend since Friday's close, despite being below the 20-day moving average.

11 sept 2026, 20:02 UTC

News

Edwards Lifesciences shares are lower despite receiving an Overweight rating and a $101 price target from Piper Sandler amid mixed TAVR coverage sentiment.

8 sept 2026, 20:02 UTC

Correlated Moves

Edwards Lifesciences Corp is declining in Tuesday's session, mirroring broader losses in the medical devices sector and trading below its 20-day moving average.

2 sept 2026, 19:16 UTC

Shares of Edwards Lifesciences Corp. are lower today amid broader market pressures from rising bond yields, reflecting a routine trading pattern.

31 ago 2026, 19:56 UTC

News

Edwards Lifesciences Corp shares are higher today, continuing momentum from Friday. The broader health care equipment sector is also showing strength.

26 ago 2026, 19:56 UTC

Edwards Lifesciences is trading higher, despite a slight pullback from earlier session highs. The stock remains above its 20-day moving average.

24 ago 2026, 19:16 UTC

Edwards Lifesciences Corp shares are higher, continuing positive momentum since Friday's close, despite pulling back from an earlier session high.

Comparación entre iguales

Cambio de precio

Edwards Lifesciences Corp previsión

Precio Objetivo

By TipRanks

18% repunte

Estimación a 12 Meses

Media 104.308 USD  18%

Máximo 110 USD

Mínimo 85 USD

De acuerdo con 15 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Edwards Lifesciences Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

15 ratings

12

Comprar

3

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
help-icon Live chat